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The Visual Impairment Intracranial Pressure







• To date 22/31 U.S. astronauts have developed some or all 
of the following findings either during or following a six-
month spaceflight: 
• Hyperopic shift 
• Choroidal folds 
• Optic Nerve Sheath Distention
• Optic nerve kinking
• Globe flattening 
• Optic disc edema (papilledema) N=7
• Cotton wool spots N=3




















- Kramer et al. 
(2012)
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Pre to Postflight Disc Edema


















1. Normal Visual Field 
with normal blind spot (in black)
2. Early Defect, Enlarged Blind
Spot and Inferior Nasal Loss
3. Severe Visual Constriction 
Prolonged Disc Edema May Lead to 




Head-ward fluid shift due to microgravity Increased intracranial pressure 
(ICP)




NASA Crewmember LPs to Date 
 LPs are done in crewmembers only if clinically indicated
 6 LPs conducted postflight in crewmembers with optic disc edema, no preflight 
LP as baseline
 Postflight measurements of ICP via LP have demonstrated elevated ICP in 5/6, 
ranging 15.4-21mmHg. Clinical intervention recommended when 
ICP>20.0mmHg










D 28.5 21.0 57
C 28  20.6 12
A 22  16.2 66
F 21.5 15.9 6
B 21  15.4 19
E 18 13.2 8
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Alternative Hypotheses:
1. Genetic VIIP predisposition to the
spaceflight environment
2. CO2 induced VIIP
3. Ocular structural changes
4. Brain structural changes






Smith & Zwart et al. 2015
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Probably a combination or other causes as well!
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A Possible Role for CO2 in VIIP? 
 CO2 is an extremely potent vasodilator, and its levels on ISS are x10 of 
Earth levels 
 A study by a joint NASA team (medical operations, LSAH, toxicology) 
evaluated in-flight data from expeditions 2-31, looking for a relationship 
between levels of CO2 and symptoms 
 A statistically significant association was found between the probability of 
headaches and average CO2, for both 24-hour and 7-day averages  
predicted
95% confidence limits
Law J, Van Baalen M, Foy M, Mason SS, Mendez C, Wear ML, Meyers VE, Alexander D. Relationship Between Carbon 
Dioxide Levels and Reported Headaches on the International Space Station. Journal of Occupational and Environmental 
Medicine 2014; 56 (5):477-483
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The VIIP Research Plan




















































The VIIP Research Plan
VIIP 12 - Analogs
VIIP 1 - Knowledge Acquisition
VIIP 3 - Technology Development
VIIP 13 –
Countermeasures
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 ICP in Short & Simulated Microgravity
 Direct ICP in Microgravity
 Mapping by VESGEN
 Data Mining – Ocular Structure
 Ocular Structure & Biomechanics
 Compartment Syndrome
 SD-OCT Analysis
 Effects of Gamma Radiation 
 VIIP Data Mining
 Venous/Arterial Compliance
 CSF Dynamics pre/postflight (MRI)
 Venous Sinus Evaluation
 Diffusion Tensor Imaging (MRI)
 Brain Gene Expression Signatures
 CSF Production & Outflow (rodents)
 Cephalad Fluid Redistribution (MRI)
 VIIP Biomarker 
 CO2 Data Mining Vision
 CO2 Data Mining headaches 
 1-Carbon Polymorphism
 Retinal Gene Expression during µG
 Retinal Gene Changes in HLS




 Ocular Health Study
 Fluid Shifts
 Occ. Surveillance Data Mining
 SD/Visual Health (MRID)
 Digital Astronaut Modeling
 Eye & Cranio-Venous Modeling
 Contribution of Medications 
 Influence of Exercise Modality
 Acute CO2 & HDT (1 hr)
 Pilot CO2 & HDT (1 day)
 Short-Term CO2 & HDT (1 wk)
 Chronic CO2 & HDT (1 month)
 Long-Term Impacts of VIIP
 Evidence Report
 Med Ops In-Flight Monitoring
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Example:




















































































Comprehensive Examinations in Ocular Health
B-scan Ocular Ultrasound Intraocular Pressure
Optical Coherence 
Tomography (OCT)
Cardiac and transcranial 
Doppler for vascular compliance Fundoscopy Computer-based vision testing
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Example:
The Fluid Shifts Study on ISS
(PI’s: Michael Stenger, Alan Hargens & 
Scott Dulchavsky)
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In-Flight Sessions (FD 45, R-45)
Test Day 1
Fluid compartmentalization measures:




Ultrasound measures of fluid shifts:
• Vascular measures of head/neck (i.e., carotid, jugular, 
vertebral, cerebral)
• Cardiovascular, ophthalmic, and portal vein measures
• Tissue thickness forehead and eyelid
Other physiological measures:
• Intracranial Pressure (CCFP/DPOAE)
• Intraocular Pressure (Tonopen/iCare and Ultrasound)
• Ocular Structure (OCT)
• Blood Pressure / Heart Rate / Vascular Resistance
Test Days 3 & 4
• Similar to Day 2 w/ addition of Chibis LBNP
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Intracranial pressure during parabolic
flight induced zero G
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Ommaya Reservoir - Commonly used intraventricular chemotherapeutic 
delivery device. Allows access to brain’s ventricular system through overlying skin 
allowing pressure measurement.
Ommaya, 0 G Flight Protocol
Ommaya Reservoir 
catheterized
Catheter attached to 
pressure transducer
Patient Supine in 
Aircraft
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5.5 6 6.5 7 7.5
Crew Average Best Cardio Health Score1
1Averaged across 200 imputed datasets
Correlation of Preflight Cardiovascular 
Score and Postflight Eye Outcomes
N=31
Best correlation = 0.91, Max = .96, Min .86, P<0.001





























 Volumetric Ophthalmic 
Ultrasound & ICP
 VIIP Hardware 
TechWatch Retinal Vascular Remodeling SD/Visual Acuity Software & In-Flight 
Tonometer Upgrade
 SD/Flight Fundoscopy Trade Study
 SD/Flight Fundoscopy Upgrade
 SD/Diagnostic OCT Trade Study
 SD/Development In-Flight diagnostic OCT
 Pilot Study: Non-Invasive CVP Device
 Vittamed ICP Device Evaluation
 Non-Invasive ICP Ground Comparison
 ICP Tech Search
 CCFP Data Mining
 Cerebrotech
 Non-Invasive ICP Flight Hardware 
Development
 Validation of Non-Invasive ICP 











 Ophthalmic and 
Optic nerve Sheath 
Modeling 
 HLS Rodent Model for VIIP 
 Digital Astronaut: VIIP Modeling
 Cranial Venous Circulation Modeling
 Acute CO2 & HDT (1 hr)
 Pilot CO2 & HDT (1 day)
 Short-Term CO2 & HDT (1 week)
 Chronic CO2 & HDT (1 month)
 Rodent Retinal Changes with HLS
 Rodent Retinal Changes with Spaceflight
 Rodent Retinal Changes with Radiation  








 In-Flight CO2 Reduction
 Fluid Shifts Flight Study (LBNP)
 Influence of Exercise Modality
 Evaluation of an Impedance Threshold Device 
 Mechanical Countermeasures – Evaluation of 
Marketed Devices 
 Thigh Cuffs Ground Evaluation 
 Pharmacological Countermeasures
 Countermeasure Optimization Ground Study
 Countermeasure Optimization In-Flight
VIIP 13: Countermeasures
 Completed
 Ongoing
 Planned
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Thank you!
